New drug aims to boost stroke recovery in major trial
Disease control
Recruiting now
This large Phase 3 trial is testing whether an investigational drug called SHPL-49 can help people recover better after an acute ischemic stroke. About 1,096 participants will receive either the drug or a placebo as an IV infusion twice daily for 7 days, alongside standard care. …
Phase: PHASE3 • Sponsor: Shanghai Hutchison Pharmaceuticals Limited • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC